SCHEMBL4076697

SCHEMBL4076697

CCC[C]=Cc1ccccc1

nearest known ligand 0.42

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
MAOB P27338 1/20 0.39
RELA Q04206 1/20 0.35
LMNA P02545 3/20 0.34
ALDH1A1 P00352 3/20 0.33
TSHR P16473 1/20 0.33
TP53 P04637 1/20 0.33
MEN1 O00255 1/20 0.33
KMT2A Q03164 1/20 0.33
TDP1 Q9NUW8 1/20 0.33
TRPA1 O75762 1/20 0.33
ALOX5 P09917 1/20 0.33
MAPK1 P28482 1/20 0.33
CYP2A6 P11509 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.32
NPC1 O15118 1/20 0.32
NR1I2 O75469 1/20 0.32
FBP1 P09467 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11424521 1.00 MAOB (0.39) MAOBRELALMNAALDH1A1TSHR
SCHEMBL15419403 0.87 LMNA (0.40) MAOBRELALMNATDP1
SCHEMBL8369796 0.85 LMNA (0.42) MAOBLMNATP53MEN1KMT2A
SCHEMBL8369798 0.85 LMNA (0.42) MAOBLMNATP53MEN1KMT2A
SCHEMBL10492237 0.85 LMNA (0.42) MAOBLMNATP53MEN1KMT2A
SCHEMBL8019896 0.84 TDP1 (0.44) LMNATP53MEN1KMT2ATDP1
SCHEMBL3499907 0.84 TDP1 (0.44) LMNATP53MEN1KMT2ATDP1
SCHEMBL8019898 0.84 TDP1 (0.44) LMNATP53MEN1KMT2ATDP1
SCHEMBL1509680 0.81 MAOB (0.42) MAOBRELALMNAALDH1A1TSHR
SCHEMBL5083636 0.81 MAOB (0.42) MAOBRELALMNAALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1894912-B1 Process for producing racemic 3-hydroxy-3-(2-phenylethyl) hexanoic acid ester SUMITOMO CHEMICAL CO (JP) 2009-08-05 EP claimed
EP-0047109-B1 RHODANINE DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND ALDOSE REDUCTASE INHIBITOR CONTAINING THE RHODANINE DERIVATIVES AS ACTIVE INGREDIENT ONO PHARMACEUTICAL CO., LTD. (JP) 1985-01-02 EP claimed
EP-0047109-A1 Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 1982-03-10 EP claimed
US-4831045-A Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 1989-05-16 US disclosed
US-4791126-A Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredients ONO PHARMACEUTICAL CO., LTD. (JP) 1988-12-13 US disclosed
US-4464382-A Rhodanine derivatives, process for their preparation, and aldose reductase inhibitor containing the rhodanine derivatives as active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 1984-08-07 US disclosed
US-4269990-A CHEMICAL INTERMEDIATES FOR 1-UNSUBSTITUTED-2-(4-INDANYL- OR 5-NAPHTHYLAMINO)-2-IMIDAZOLINE, USEFUL AS DRUGS BASF AKTIENGESELLSCHAFT (DE) 1981-05-26 US disclosed
US-4232151-A ANTIBIOTICS SHIONOGI & CO., LTD. (JP) 1980-11-04 US disclosed
US-4223132-A Selective conversion of benzyl alcohol carboxylates to the free acid form SHIONOGI & CO., LTD. (JP) 1980-09-16 US disclosed